Search Results - "Wyngaert, Tim Van den"

Refine Results
  1. 1

    Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders-An Update by Dewulf, Jonatan, Adhikari, Karuna, Vangestel, Christel, Wyngaert, Tim Van Den, Elvas, Filipe

    Published in Cancers (11-07-2020)
    “…Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are molecular imaging strategies that typically use radioactively…”
    Get full text
    Journal Article
  2. 2

    Preventing, identifying, and managing medication-related osteonecrosis of the jaw: a practical guide for nurses and other allied healthcare professionals by Drudge-Coates, Lawrence, Van den Wyngaert, Tim, Schiødt, Morten, van Muilekom, H. A. M., Demonty, Gaston, Otto, Sven

    Published in Supportive care in cancer (01-09-2020)
    “…Background Medication-related osteonecrosis of the jaw (MRONJ) is an infrequent, but potentially serious, adverse event that can occur after exposure to…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Molecular Imaging of Apoptosis: The Case of Caspase-3 Radiotracers by Beroske, Lucas, Van den Wyngaert, Tim, Stroobants, Sigrid, Van der Veken, Pieter, Elvas, Filipe

    “…The molecular imaging of apoptosis remains an important method for the diagnosis and monitoring of the progression of certain diseases and the evaluation of…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Topical Honey Application to Reduce Radiation-Induced Oral Mucositis: A Therapy too Sweet to Ignore? by Van den Wyngaert, Tim, MD, PhD

    “…Article Title and Bibliographic Information Systematic review and meta-analysis on the use of honey to protect from the effects of radiation-induced oral…”
    Get full text
    Journal Article
  8. 8

    Second-line erlotinib after failure of pemetrexed-containing chemotherapy in advanced non-small cell lung cancer (NSCLC): Real-world effectiveness, safety and tolerability by Germonpré, Paul, Van den Wyngaert, Tim

    Published in PloS one (11-04-2019)
    “…Little data is available on patients with advanced non-squamous NSCLC treated with erlotinib specifically after failure of first-line pemetrexed-containing…”
    Get full text
    Journal Article
  9. 9

    EANM practice guideline for quantitative SPECT-CT by Dickson, John C., Armstrong, Ian S., Gabiña, Pablo Minguez, Denis-Bacelar, Ana M., Krizsan, Aron K., Gear, Jonathan M., Van den Wyngaert, Tim, de Geus-Oei, Lioe-Fee, Herrmann, Ken

    “…  Purpose Quantitative SPECT-CT is a modality of growing importance with initial developments in post radionuclide therapy dosimetry, and more recent expansion…”
    Get full text
    Journal Article
  10. 10

    Assessment of regional and total skeletal metabolism using 18F-NaF PET/CT in patients with chronic kidney disease by Usmani, Sharjeel, Ahmed, Najeeb, Gnanasegaran, Gopinath, Marafi, Fahad, Bani-Mustafa, Ahmed, Van den Wyngaert, Tim

    Published in Annals of nuclear medicine (01-07-2024)
    “…Objective The study aims to assess regional and total bone metabolic activity in patients with chronic kidney disease using Na[ 18 F]F PET and correlation…”
    Get full text
    Journal Article
  11. 11

    Update on imaging in chronic kidney disease-mineral and bone disorder: promising role of functional imaging by Usmani, Sharjeel, Ahmed, Najeeb, Gnanasegaran, Gopinath, Marafi, Fahad, van den Wyngaert, Tim

    Published in Skeletal radiology (01-05-2022)
    “…Disorders of mineral metabolism and bone disease are common complications in chronic kidney disease (CKD) patients and are associated with increased morbidity…”
    Get full text
    Journal Article
  12. 12

    Quality Assessment in FDG-PET/CT Imaging of Head-and-Neck Cancer: One Home Run Is Better Than Two Doubles by Van den Wyngaert, Tim, De Schepper, Stijn, Carp, Laurens

    Published in Frontiers in oncology (14-08-2020)
    “…2-deoxy-2-[ 18 F]fluoro-D-glucose (FDG) positron emission tomography (PET)/computed tomography (CT) is indicated in head-and-neck cancer for the initial workup…”
    Get full text
    Journal Article
  13. 13

    Radiographic predictors for MRONJ in oncologic patients undergoing tooth extraction by Moreno-Rabié, Catalina, Lapauw, Laurence, Gaêta-Araujo, Hugo, Ferreira-Leite, André, Coucke, Wim, van den Wyngaert, Tim, Jacobs, Reinhilde

    Published in Scientific reports (04-07-2022)
    “…Tooth extraction is a risk factor for the development of osteonecrosis of the jaw following treatment with antiresorptive drugs (ARDs), but not all extraction…”
    Get full text
    Journal Article
  14. 14

    Local radiographic risk factors for MRONJ in osteoporotic patients undergoing tooth extraction by Moreno‐Rabié, Catalina, Gaêta‐Araujo, Hugo, Ferreira‐Leite, André, Coucke, Wim, Gielen, Evelien, Van den Wyngaert, Tim, Jacobs, Reinhilde

    Published in Oral diseases (01-04-2024)
    “…Objective To identify local radiographic risk factors for Medication‐Related Osteonecrosis of the Jaws (MRONJ) in osteoporotic patients treated with…”
    Get full text
    Journal Article
  15. 15

    Radionuclide Imaging of Cytotoxic Immune Cell Responses to Anti-Cancer Immunotherapy by Lauwerys, Louis, Smits, Evelien, Van den Wyngaert, Tim, Elvas, Filipe

    Published in Biomedicines (05-05-2022)
    “…Cancer immunotherapy is an evolving and promising cancer treatment that takes advantage of the body's immune system to yield effective tumor elimination…”
    Get full text
    Journal Article
  16. 16

    Evaluation of [18F]CP18 as a Substrate-Based Apoptosis Imaging Agent for the Assessment of Early Treatment Response in Oncology by Rapic, Sara, Vangestel, Christel, Elvas, Filipe, Verhaeghe, Jeroen, den Wyngaert, Tim Van, wyffels, Leonie, Pauwels, Patrick, Staelens, Steven, Stroobants, Sigrid

    Published in Molecular imaging and biology (01-08-2017)
    “…Purpose The substrate-based positron emission tomography (PET) tracer [ 18 F]CP18 is capable of detecting the activity of caspase-3/7, two key executioner…”
    Get full text
    Journal Article
  17. 17

    RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review by van Dam, Peter A, Verhoeven, Yannick, Jacobs, Julie, Wouters, An, Tjalma, Wiebren, Lardon, Filip, Van den Wyngaert, Tim, Dewulf, Jonatan, Smits, Evelien, Colpaert, Cécile, Prenen, Hans, Peeters, Marc, Lammens, Martin, Trinh, Xuan Bich

    “…RANK ligand (RANKL) is a member of the tumor necrosis factor alpha superfamily of cytokines. It is the only known ligand binding to a membrane receptor named…”
    Get full text
    Journal Article
  18. 18

    Early Changes in [18F]FDG Uptake as a Readout for PI3K/Akt/mTOR Targeted Drugs in HER-2-Positive Cancer Xenografts by Dockx, Yanina, Vangestel, Christel, Van den Wyngaert, Tim, Huizing, Manon, De Bruycker, Sven, Pauwels, Patrick, Staelens, Steven, Stroobants, Sigrid

    Published in Molecular imaging (2021)
    “…We investigated the potential use of [18F]FDG PET as a response biomarker for PI3K pathway targeting therapies in two HER-2-overexpressing cancer models…”
    Get full text
    Journal Article
  19. 19

    From SPECT/CT towards absolute quantification? - the case of unilateral condylar hyperplasia of the mandible by De Schepper, Stijn, Gnanasegaran, Gopinath, De Vos, Wouter, Van de Casteele, Elke, Dickson, John C., Van den Wyngaert, Tim

    Published in EJNMMI physics (23-08-2024)
    “…Background Unilateral condylar hyperplasia (UCH) of the mandible is a rare condition characterized by asymmetric growth of the mandibular condyles. Bone…”
    Get full text
    Journal Article
  20. 20

    Absolute Quantification in Diagnostic SPECT/CT: The Phantom Premise by De Schepper, Stijn, Gnanasegaran, Gopinath, Dickson, John C, Van den Wyngaert, Tim

    Published in Diagnostics (Basel) (11-12-2021)
    “…The application of absolute quantification in SPECT/CT has seen increased interest in the context of radionuclide therapies where patient-specific dosimetry is…”
    Get full text
    Journal Article